Saturday 21 May 2011
Anemia prescription drug that causes more harm than good
Read about Epogen, also known as Procrit, in this Bloomberg report. "A drug sold by Amgen Inc. and Johnson & Johnson for people with anemia didn’t reduce heart damage in patients who’d experienced heart attacks and may increase the chances of recurrence or death, a study found. Epogen, approved in 1989 as the first drug for Thousand Oaks, California-based Amgen, is used by patients undergoing kidney dialysis to boost their depleted red blood cells. J&J sells the drug as Procrit, mostly for cancer patients getting chemotherapy."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment